160 related articles for article (PubMed ID: 29774526)
21. Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.
Chiriaco M; Salfa I; Di Matteo G; Rossi P; Finocchi A
Pediatr Allergy Immunol; 2016 May; 27(3):242-53. PubMed ID: 26680691
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.
Bionda C; Li XJ; van Bruggen R; Eppink M; Roos D; Morel F; Stasia MJ
Hum Genet; 2004 Oct; 115(5):418-27. PubMed ID: 15338276
[TBL] [Abstract][Full Text] [Related]
23. Effects of Alu insertions on gene function.
Szmulewicz MN; Novick GE; Herrera RJ
Electrophoresis; 1998 Jun; 19(8-9):1260-4. PubMed ID: 9694261
[TBL] [Abstract][Full Text] [Related]
24. Genetic and biochemical background of chronic granulomatous disease.
Jurkowska M; Bernatowska E; Bal J
Arch Immunol Ther Exp (Warsz); 2004; 52(2):113-20. PubMed ID: 15179325
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic control of retrotransposon expression in human embryonic stem cells.
Macia A; Muñoz-Lopez M; Cortes JL; Hastings RK; Morell S; Lucena-Aguilar G; Marchal JA; Badge RM; Garcia-Perez JL
Mol Cell Biol; 2011 Jan; 31(2):300-16. PubMed ID: 21041477
[TBL] [Abstract][Full Text] [Related]
26. Identification of a thermolabile component of the human neutrophil NADPH oxidase. A model for chronic granulomatous disease caused by deficiency of the p67-phox cytosolic component.
Erickson RW; Malawista SE; Garrett MC; Van Blaricom G; Leto TL; Curnutte JT
J Clin Invest; 1992 May; 89(5):1587-95. PubMed ID: 1314852
[TBL] [Abstract][Full Text] [Related]
27. Non-homologous recombination between Alu and LINE-1 repeats caused a 430-kb deletion in the dystrophin gene: a novel source of genomic instability.
Suminaga R; Takeshima Y; Yasuda K; Shiga N; Nakamura H; Matsuo M
J Hum Genet; 2000; 45(6):331-6. PubMed ID: 11185740
[TBL] [Abstract][Full Text] [Related]
28. The Influence of LINE-1 and SINE Retrotransposons on Mammalian Genomes.
Richardson SR; Doucet AJ; Kopera HC; Moldovan JB; Garcia-Perez JL; Moran JV
Microbiol Spectr; 2015 Apr; 3(2):MDNA3-0061-2014. PubMed ID: 26104698
[TBL] [Abstract][Full Text] [Related]
29. Involvement of Conserved Amino Acids in the C-Terminal Region of LINE-1 ORF2p in Retrotransposition.
Christian CM; Sokolowski M; deHaro D; Kines KJ; Belancio VP
Genetics; 2017 Mar; 205(3):1139-1149. PubMed ID: 28100588
[TBL] [Abstract][Full Text] [Related]
30. Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase.
Roos D; de Boer M; Köker MY; Dekker J; Singh-Gupta V; Ahlin A; Palmblad J; Sanal O; Kurenko-Deptuch M; Jolles S; Wolach B
Hum Mutat; 2006 Dec; 27(12):1218-29. PubMed ID: 16972229
[TBL] [Abstract][Full Text] [Related]
31. Novel Diagnostic Tool for p47
Wrona D; Siler U; Reichenbach J
Mol Ther Methods Clin Dev; 2019 Jun; 13():274-278. PubMed ID: 30859112
[TBL] [Abstract][Full Text] [Related]
32. Alu retrotransposition-mediated deletion.
Callinan PA; Wang J; Herke SW; Garber RK; Liang P; Batzer MA
J Mol Biol; 2005 May; 348(4):791-800. PubMed ID: 15843013
[TBL] [Abstract][Full Text] [Related]
33. APOBEC3G oligomerization is associated with the inhibition of both Alu and LINE-1 retrotransposition.
Koyama T; Arias JF; Iwabu Y; Yokoyama M; Fujita H; Sato H; Tokunaga K
PLoS One; 2013; 8(12):e84228. PubMed ID: 24367644
[TBL] [Abstract][Full Text] [Related]
34. Alu elements: an intrinsic source of human genome instability.
Ade C; Roy-Engel AM; Deininger PL
Curr Opin Virol; 2013 Dec; 3(6):639-45. PubMed ID: 24080407
[TBL] [Abstract][Full Text] [Related]
35. Rescuing Alu: recovery of new inserts shows LINE-1 preserves Alu activity through A-tail expansion.
Wagstaff BJ; Hedges DJ; Derbes RS; Campos Sanchez R; Chiaromonte F; Makova KD; Roy-Engel AM
PLoS Genet; 2012; 8(8):e1002842. PubMed ID: 22912586
[TBL] [Abstract][Full Text] [Related]
36. Chronic granulomatous disease in Latin American patients: clinical spectrum and molecular genetics.
Agudelo-Flórez P; Prando-Andrade CC; López JA; Costa-Carvalho BT; Quezada A; Espinosa FJ; de Souza Paiva MA; Roxo P; Grumach A; Jacob CA; Carneiro-Sampaio MM; Newburger PE; Condino-Neto A
Pediatr Blood Cancer; 2006 Feb; 46(2):243-52. PubMed ID: 16123991
[TBL] [Abstract][Full Text] [Related]
37. Replicative Senescence-Associated LINE1 Methylation and LINE1-Alu Expression Levels in Human Endothelial Cells.
Ramini D; Latini S; Giuliani A; Matacchione G; Sabbatinelli J; Mensà E; Bacalini MG; Garagnani P; Rippo MR; Bronte G; Bonafè M; Cardelli M; Olivieri F
Cells; 2022 Nov; 11(23):. PubMed ID: 36497059
[TBL] [Abstract][Full Text] [Related]
38. Tandem insertions of Alu elements.
El-Sawy M; Deininger P
Cytogenet Genome Res; 2005; 108(1-3):58-62. PubMed ID: 15545716
[TBL] [Abstract][Full Text] [Related]
39. [Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease].
Nunoi H; Ishibashi F
Hum Cell; 1999 Sep; 12(3):103-8. PubMed ID: 10695016
[TBL] [Abstract][Full Text] [Related]
40. Functional impact of the human mobilome.
Babatz TD; Burns KH
Curr Opin Genet Dev; 2013 Jun; 23(3):264-70. PubMed ID: 23523050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
